-+ 0.00%
-+ 0.00%
-+ 0.00%

FICERAFUSP ALFA 2000MG Q2W DEMONSTRATES DEEP, DURABLE RESPONSES IN 1L R/M HPV-NEGATIVE HNSCC AND SUPPORTS DEVELOPMENT OF LESS FREQUENT DOSING REGIMEN

Reuters·02/19/2026 21:30:44

Please log in to view news